In vitro characterization and molecular epidemiology of Cryptococcus spp. isolates from non-HIV patients in Guangdong, China

Autor: Penglei Wang, Yongming Li, Lei Gao, Xiang Tang, Dandian Zheng, Kuihai Wu, Luxia Wang, Penghao Guo, Feng Ye

Publikováno v: Frontiers in Microbiology, Vol 14 (2024)

BackgroundThe burden of cryptococcosis in mainland China is enormous. However, the in vitro characterization and molecular epidemiology in Guangdong, a key region with a high incidence of fungal infection in China, are not clear.MethodsFrom January 1

Externí odkaz: https://doaj.org/article/b18ec17883b34deb87653fdfcb72a64f

Prevalence of Lower Respiratory Tract Fungal Infection at a Tertiary Care Hospital in Central Madhya Pradesh, India: A Cross-sectional Study

Autor: Bhavya Chiti, Riti Jain Seth, Kumkum Madoriya

Publikováno v: National Journal of Laboratory Medicine, Vol 12, Iss 4, Pp MO09-MO12 [30] Rafat Z, Hashemi SJ, Ashrafi K, Nikokar I, Jafari A, Rahimi Foroushani A, et al. Fungal isolates of the respiratory tract in symptomatic patients hospitalized in pulmonary units: A mycological and molecular epidemiologic study. J Multidiscip Healthc. 2020;13:661-69. [31] Zomorodian K, Rahimi MJ, Pakshir K, Motamedi M, Ghiasi MR, Rezashah H. Determination of antifungal susceptibility patterns among the clinical isolates of Candida species. J Glob Infect Dis. 2011;3(4):357-60. [32] Khadka S, Sherchand JB, Pokhrel BM, Parajuli K, Mishra SK, Sharma S, et al. Isolation, speciation and antifungal susceptibility testing of Candida isolates from various clinical specimens at a tertiary care hospital, Nepal. BMC Res Notes. 2017;10(1):218. [33] Perlin DS. Echinocand in resistance in Candida. Clin Infect Dis. 2015;61(Suppl 6):S612-17. [34] Ahir HR, Gohil BP. Prevalence of fungal infections in patients attending tertiary care teaching hospital, middle Gujarat, India. IJMR. 2020;5(3):364-67. PARTICULARS OF CONTRIBUTORS: 1. Junior Resident, Department of Microbiology, Netaji Subhash Chandra Bose Medical College, Jabalpur, Madhya Pradesh, India. 2. Professor and Head, Department of Microbiology, Netaji Subhash Chandra Bose Medical College, Jabalpur, Madhya Pradesh, India. 3. Assistant Professor, Department of Microbiology, Netaji Subhash Chandra Bose Medical College, Jabalpur, Madhya Pradesh, India. PLAGIARISM CHECKING METHODS: [Jain H et al.] • Plagiarism X-checker: Mar 21, 2023 • Manual Googling: Jun 10, 2023 • iThenticate Software: Sep 04, 2023 (15%) NAME, ADDRESS, E-MAIL ID OF THE CORRESPONDING AUTHOR: Etymology: Author Origin Dr. Riti Jain Seth, Professor and Head, Department of Microbiology, Netaji Subhash Chandra Bose Medical College, Jabalpur-482003, Madhya Pradesh, India. E-mail: drsethriti@gmail.com Date of Submission: Mar 14, 2023 Date of Peer Review: Apr 19, 2023 Date of Acceptance: Sep 05, 2023 Date of Publishing: Oct 01, 2023 Author declaration: • Financial or Other Competing Interests: None • Was Ethics Committee Approval obtained for this study? Yes • Was informed consent obtained from the subjects involved in the study? No • For any images presented appropriate consent has been obtained from the subjects. NA Emendations: 8 (2023)

Introduction: The incidence of fungal infections and resistant isolates has risen exponentially due to multiple factors. This makes the isolation of fungi, performing identification, and susceptibility testing a necessary routine microbiological proc

Externí odkaz: https://doaj.org/article/2ef8c8fc33a74c36b4cd8aa98d4ebc74

Evidence-based management of dermatophytosis in India today

Autor: Aparajita Ghosh, Saumya Panda

Publikováno v: Apollo Medicine, Vol 20, Iss 1, Pp 32-37 (2023)

Introduction: Dermatophyte infection has become extremely resistant and widespread in all parts of India during the past decade. A change in the major causative organism has been identified to be a major factor behind the change in the character of t

Externí odkaz: https://doaj.org/article/1b709838357e48799f31258b82ccba8d

Novel Antifungals and Aspergillus Section Terrei with Potpourri Susceptibility Profiles to Conventional Antifungals

Autor: Roya Vahedi-Shahandashti, Jos Houbraken, Mike Birch, Cornelia Lass-Flörl

Publikováno v: Journal of Fungi, Vol 9, Iss 6, p 649 (2023)

The epidemiology of invasive fungal infections (IFIs) is currently changing, driven by aggressive immunosuppressive therapy, leading to an expanded spectrum of patients at risk of IFIs. Aspergillosis is a leading cause of IFIs, which usually affects

Externí odkaz: https://doaj.org/article/b233f00c839443ecb2782ee49f64ab1e

Candidal onychomycosis: Clinicoepidemiological profile, prevailing strains, and antifungal susceptibility pattern–a study from a tertiary care hospital

Autor: Shagufta Rather, Abid Keen, Faizan Younus Shah, Atiya Yaseen, Shaiqa Farooq, Asifa Bakhshi

Publikováno v: Indian Journal of Dermatology, Vol 66, Iss 2, Pp 132-137 (2021)

Background: Despite an increasing trend of onychomycosis caused by Candida species in recent years, there is a scarcity of published data. Objective: To determine the epidemiological and clinical characteristics of Candida onychomycosis, to identify

Externí odkaz: https://doaj.org/article/5298e427cb3a48ca92da24da0e81d1af